#CMV

Researchers analyzed 10 biomarkers associated with biological aging among a group of HIV-positive and -negative Europeans.

The drug is approved to cut the risk of CMV reactivation following a stem cell transplant.

The grant will help fund a Phase I clinical trial in humans.

A new vaccine appears to have completely cured monkeys of simian immunodeficiency virus, a primate cousin of HIV, raising hopes for the field...

Low-level HIV replication in semen is associated with the shedding of herpes viruses.

An experimental cream containing a drug used to treat a serious eye infection in people with AIDS has shown potential as a therapy for pre-can...

A new type of vaccine has resulted in successful control of SIV (simian immunodeficiency virus), the monkey version of HIV, in about half the...

Adding the anti-cytomegalovirus (CMV) drug Valcyte (valgancyclovir) to an antiretroviral (ARV) regimen calms down immune system inflammation i...

The integrase inhibitor Isentress (raltegravir) could lead to the development of an effective treatment against all herpes viruses, including...

People who are 55 or older have roughly the same degree of immune activation as younger people, according to a small study presented Wednesday...

HIV-positive people are aging faster than those not infected HIV, possibly due to the body’s hyperactive response to the virus.

Researchers have discovered several drugs with the potential for treating a number of diseases caused by herpes viruses, including Kaposi’s sa...

Bavituximab is a new type of antiviral drug that could work against a number of different types of viral infections—possibly even agains...

Eric Brun-Sanglard, an HIV positive interior designer, lost his sight 11 years ago. But when he got his own reality TV show...

Can oral ganciclovir prevent vision loss?